The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...

Since the discovery of statins and the Scandinavian Simvastatin Survival Study (4S) results three decades ago, remarkable advances have been made in the treatment of dyslipidaemia, a major risk factor ...

Discover Patanjali’s Madhugrit, an Ayurvedic diabetes solution blending natural herbs with scientific research to manage ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British research shows.

The highest dose of an experimental pill developed by Eli Lilly dramatically lowered an inherited form of high cholesterol in a mid-stage trial, according to data presented at a medical meeting on ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

The decision follows a September meeting of the agency's Gastrointestinal Drugs Advisory Committee ... Untreated, PBC can ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Continue to advance hypoimmune technology in three trials across five indications in type 1 diabetes, B-cell mediated autoimmune ... career has participated in the development of 10 approved drugs in ...